NCT05116735

Brief Summary

Purpose : The primary goals of this study were to determine the prevalence and risk factors of occult CBC and recurrence, as well as the relationship between occult cysto-biliary communications manifested as postoperative biliary leakage and recurrence. The secondary goal was to use chemical analysis of hydatid cyst fluid to assess excessive bilirubin and alkaline phosphatase levels as predictors of fistula and recurrence. Methods: This prospective multi-center experimental and follow-up study of six years duration was conducted at the hepato-biliary pancreatic units of our universities hospitals from September 2010 to September 2016. Initially, 292 patients were included, but only 244 patients enrolled in the final study.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
244

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2010

Longer than P75 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2010

Completed
6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2016

Completed
5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 29, 2021

Completed
13 days until next milestone

First Posted

Study publicly available on registry

November 11, 2021

Completed
Last Updated

June 28, 2023

Status Verified

June 1, 2023

Enrollment Period

6 years

First QC Date

October 29, 2021

Last Update Submit

June 26, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • biliary leakage

    incidence of biliary leakage detected clinically, sonar or CT

    30 days postoperatively

  • recurrence

    detection of recurrence by CT and sonar abdomen

    5 years

Secondary Outcomes (1)

  • biochemical analysis of hydatid cyst fluid

    intraoperative

Study Arms (1)

laparoscopic partial cystectomy with omentoplasty

EXPERIMENTAL

laparoscopic partial cystectomy with omentoplasty

Procedure: laparoscopic partial cystectomy with omentoplasty

Interventions

laparoscopic partial cystectomy with omentoplasty

laparoscopic partial cystectomy with omentoplasty

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Stages CE2
  • CE3b According to the WHO-IWGE classification
  • solitary
  • symptomatic or asymptomatic
  • superficial cyst
  • cases not suited for hepatic resection as the cyst wall abutting critical vascular and biliary structures as hepatic resection is harmful or excessive loss of hepatic tissue

You may not qualify if:

  • stages CL, CE1, CE3a, CE4, CE5 according to WHO-IWGE classification of the hydatid cyst
  • preoperative total bilirubin level greater than 2.0 mg/dl and direct bilirubin level greater than 1.5 mg/dl
  • common bile duct dilatation greater than 10 mm , or CT, or MRI, previous percutaneous treatment
  • recurrent cases after any type of surgery, cases with associated extrahepatic or extra-abdominal hydatid cyst
  • cysts affecting an entire lobe or the main pedicles
  • stages Cysts that are complicated (ruptured or diseased cysts), deep cysts .Patients who refuse intervention, have a surgical contraindication, are pregnant, have hydatid cysts in both lobes of the liver, previous liver surgery, liver abscess, frank CBC, cases lost during follow-up, cases who refused to take albendazole, or cases who developed albendazole-related issues (disturbed liver function).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant professour of general and laparoscopic surgery

Study Record Dates

First Submitted

October 29, 2021

First Posted

November 11, 2021

Study Start

September 1, 2010

Primary Completion

September 1, 2016

Study Completion

September 1, 2021

Last Updated

June 28, 2023

Record last verified: 2023-06